Primary Job Title CSO & Co-Founder Primary Organization eNUVIO
LinkedIn View on LinkedIn
Specializing in ion channel pharmacology, Mark completed his doctoral degree at McGill University and continued his training at The Neuro in Montréal to develop new iPSC-derived models of neurodegenerative diseases.